Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPETE: Anticoagulation vs Anti-platelet vs Migraine Therapy for Migraine with PFO
NCT05546320Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2022
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, clopidogrel, rivaroxaban in migraine, sponsored by Chinese Academy of Medical Sciences. Started Oct 2022; status: completed.
02
Drugs
aspirinclopidogrelrivaroxaban
03
Conditions
migraine
Beyond the preview
Go deeper on NCT05546320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05546320.